Circle Biologics, Inc. — Form D/A
Circle Biologics, Inc. of MINNEAPOLIS, MN, a company, filed a Form D amendment with the SEC on 2012-10-25. The offering totals $1.5M, of which $617K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-10-25
- Form: D/A
- Accession: 0001543622-12-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $617K
- Remaining: $883K
- Minimum investment: $100K
- Investors: 5
- Date of first sale: 2012-07-20
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-182937
Issuer
- Name: Circle Biologics, Inc.
- CIK: 0001543622
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 3650 ANNAPOLIS LANE, MINNEAPOLIS, MN, 55447
- Phone: 763-577-0900
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| ELIZABETH F COULL | Director | MINNEAPOLIS, MN |
| FRED F KOLB | Director | MINNEAPOLIS, MN |
| RICHARD F KYLE, M.D. | Director | MINNEAPOLIS, MN |
| MATTHEW KYLE | Executive Officer | MINNEAPOLIS, MN |
| ELIZABETH F. COULL | Director | MINNEAPOLIS, MN |
| RICHARD F. KYLE, M.D. | Director | MINNEAPOLIS, MN |
| FRED F. KOLB | Director | MINNEAPOLIS, MN |
Other filings by this issuer (3)
More